New Key Statistics Module, Z-Score and F-Score
BUE:GSK Key Ratios
Market Cap ARS M | 72,846,763.03 |
Enterprise Value ARS M | 89,155,739.96 |
P/E(ttm) | 14.79 |
PE Ratio without NRI | 13.38 |
Forward PE Ratio | 13.28 |
Price/Book | 4.41 |
Price/Sales | 2.10 |
Price/Free Cash Flow | 11.98 |
Price/Owner Earnings | 10.92 |
Payout Ratio % | 0.55 |
Revenue (TTM) ARS M | 17,265,373.00 |
EPS (TTM) ARS | 280.59 |
Beneish M-Score | -2.69 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -6.50 |
EV-to-EBIT | 12.06 |
EV-to-EBITDA | 8.90 |
PEG | 13.38 |
Shares Outstanding M | 8,156.29 |
Net Margin (%) | 14.59 |
Operating Margin % | 21.97 |
Pre-tax Margin (%) | 17.93 |
Quick Ratio | 0.58 |
Current Ratio | 0.87 |
ROA % (ttm) | 7.56 |
ROE % (ttm) | 34.58 |
ROIC % (ttm) | 12.07 |
Dividend Yield % | 2.21 |
Altman Z-Score | 1.82 |
BUE:GSK Number of Guru Trades
BUE:GSK Volume of Guru Trades
Gurus Latest Trades with BUE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BUE:GSK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data